Tag: CBT > Cannabis Medical Value

Cannabis Industry Research

Medical Marijuana Act Signed by Biden Would Hinder Research Under Rescheduling

The Medical Marijuana and Cannabidiol Research Expansion Act’s requirements would remain under Schedule III, a congressional researcher says.

September 20, 2024

Federal Cannabis Legalization

25 GOP Lawmakers Condemn Cannabis Rescheduling in New Letter

Sen. James Lankford and Rep. Pete Sessions spearheaded the letter sent to Attorney General Merrick Garland, saying rescheduling lacks “adequate science.”

July 12, 2024

Cannabis Rescheduling

US Congressman Attempts to Sway DEA From Rescheduling Cannabis

Rep. Andy Harris claims the FDA’s eight-factor analysis on cannabis was “flawed,” leading to a “misguided” recommendation to reschedule.

February 2, 2024